Equifax Inc (EFX) is dealing with a series of developments that have grazed the bio-tech market. Highlighting from a SWOT perspective, opportunities, and potential threats in the strategic landscape have sprouted, a perspective moving in both the negative and positive directions. The stock recently saw a decline catalyzed by EVP Bryson Koehler's selling off his shares. Interestingly, though, the company has some advancements such as the robust launch of 'Digital Identity as a Service', an innovative stride into technology-based solutions. Despite reporting disappointing sales recently, joining other significant firms like Synovus Financial on a downfall on a particular Thursday, potentials such as Q1 Earnings still dangle with speculations rife about the outcome. Lastly, Equifax is considered modestly undervalued, giving room for growth with portfolio manager Wallace Weitz investing 1.48% stake in the company.
Equifax Incorporated EFX News Analytics from Wed, 13 Oct 2021 07:00:00 GMT to Tue, 23 Apr 2024 07:00:00 GMT -
Rating -3
- Innovation 4
- Information 6
- Rumor -5
